Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03144752 · ClinicalTrials.gov registry record
Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 298
- Enrollment target
NCT03144752: Completed study, sponsored by Janssen Research & Development.
NCT03144752 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 298 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03144752 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 298 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if medical, biological, psychological, and social risk factors can be used to develop algorithms that will predict perinatal depression (PND). Data capture will include baseline participant medical, psychological and family history, blood biomarkers, and psychosocial assessments.
Primary Outcome
Blood samples will be collected to evaluate biomarkers for perinatal depression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2019-05-05 |
What the finished NCT03144752 record still lists
NCT03144752 is an observational study that tracks outcomes without assigning an intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03144752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03144752 about?
NCT03144752 is a clinical study titled "Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression". The purpose of this study is to determine if medical, biological, psychological, and social risk factors can be used to develop algorithms that will predict perinatal depression (PND). Data capture will include baseline participant medical, psychological and family history, blood biomarkers, and psy...
What is the current status of trial NCT03144752?
This trial is currently completed. The enrollment target is 298 participants. The study started on 2017-04-14. Estimated completion is 2019-05-05.
Who is sponsoring clinical trial NCT03144752?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI